DONOR OOCYTES vs. PATIENT OOCYTES

• Alternative, not treatment

• Choice based on:

  • Age
  • FSH, E2
  • Response to gonadotropins
  • Failed IVF cycles

• SART LBR 40%

• Issues

  • Oocyte sharing
  • Payment to donors
  • Health risks to donor

• Counseling

Previous slide

Next slide

Back to first slide

View graphic version